HOME >> MEDICINE >> NEWS
Life-saving properties of beta blockers extend to more patients

antiarrhythmic drugs in combination with beta blocker therapy compared with antiarrhythmic therapy alone."

This trend was not seen in patients with ICDs, likely reflecting the "significant impact of ICD therapy on sudden cardiac death and the difficulty in further decreasing event rates," they add.

The authors note that patients treated with beta blockers were younger, had higher EF rates, higher rates of recent angina, and more recent heart attacks.

A limitation of the study was the inability to randomize the use of beta blockers because the administration of this therapy was left to the discretion of the referring physicians. Another drawback was that the effects of beta blockers in patients who received antiarrhythmic drugs may be obscured because several of these drugs possess some beta blocker activity.

Even so, the significant decrease in the overall death rate of these high-risk patients taking beta blockers and who hadn't had a recent heart attack combined with previous similar evidence lead the authors' to conclude "it is appropriate to prescribe these drugs in patients with the characteristics of those enrolled in the MUSTT trial."


'"/>

Contact: Carole Bullock
carole.bullock@heart.org
214-706-1279
American Heart Association
28-Oct-2002


Page: 1 2 3

Related medicine news :

1. Life-saving imaging techniques developed at Oxford University
2. Stanford researcher dusts off old drug; uncovers new anti-rejection properties
3. UI-led study shows experimental anti-cancer drug also has anti-HIV properties
4. Secret agents secret revealed - shaken martinis have superior antioxidant properties to those that are stirred
5. Beta-blockers may help broader group of patients with heart problems
6. Beta blockers after cardiac surgery reduce length of stay and complications
7. Beta blockers usage low despite insurance
8. Beta blockers cost effective to society for heart failure treatment
9. Beta-blockers protect brain during bypass surgery
10. Beta-blockers after heart surgery show double benefits
11. Beta-blockers improve outcomes of bypass surgery

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/26/2017)... ... February 26, 2017 , ... This is an ... world’s first to be ISO/IEC 17025:2005 INAB accredited for Der p 1 (house ... is the globally recognised standard that sets out requirements for the technical competence ...
(Date:2/26/2017)... ... February 26, 2017 , ... ... distribution in North America, today announced it would be offering some it’s exclusive ... prides itself on crafting quality and unique baby clothing/feeding products, will team up ...
(Date:2/26/2017)... ... February 26, 2017 , ... ... new technology standard in staffing, scheduling, and reporting for healthcare organizations. This ... activity throughout the entire staffing process. StaffBridge technology improves staffing efficiency, maximizes ...
(Date:2/26/2017)... Florida (PRWEB) , ... February 26, 2017 , ... ... (PD) patients after receiving cognitive rehabilitation, according to a study released today at ... known that cognitive rehabilitation programs are proven to be effective in improving cognitive ...
(Date:2/25/2017)... ... , ... FCPX users now have the ability to sharpen a desired color ... users have total control over sharpening amount, sharpening radius, threshold, horizontal sharpening, vertical sharpening, ... users can visually see the color range effected with ease all within Final ...
Breaking Medicine News(10 mins):
(Date:2/24/2017)...  Today, exocad America and the Biodenta Group ... path to produce 510(K) cleared, in-house milled, custom ... into exocad DentalCAD software. In order to achieve ... Processes (GMP,s) into their organization, sign up as ... audit process. Then, dental labs can use Biodenta,s milling ...
(Date:2/24/2017)... -- Research and Markets has announced the addition of the ... their offering. ... research Hemophilia Drugs Price Analysis and Strategies - 2016, provides drug pricing ... the following questions: What are the key ... in the Global Hemophilia market? What are the unit ...
(Date:2/24/2017)... , Feb. 24, 2017 Juan ... & Associates PC , a boutique securities firm headquartered ... York City , announces that a class action ... Massachusetts  against Inotek Pharmaceuticals Corporation (NASDAQ: ... the Company,s securities between July 23, 2015 and December 30, ...
Breaking Medicine Technology:
Cached News: